Feb 06, 2020
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $1.03 to $0.10.
The split itself did not change the total investment value.
Bellicum Pharmaceuticals, Inc. (BLCM) trades on the NASDAQ Capital Market in the Biotechnology industry.
Bellicum Pharmaceuticals, Inc. company overviewThe latest split shown was on February 6, 2020. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
This history records one reverse split, on February 6, 2020.